"Das Herzzentrum Leipzig bietet mit seinen 440 Betten und zehn tagesklinischen Betten in der Universitätsklinik für Herzchirurgie, der Universitätsklinik für Kardiologie – Helios Stiftungsprofessur und der Universitätsklinik für Kinderkardiologie sowie den Abteilungen für Anästhesiologie und Radiologie Hochleistungsmedizin rund um das Herz."

During the past decade, Herzzentrum Leipzig GmbH conducted 116 clinical trials. In the 10-year time frame, 116 clinical trials started and 39 clinical trials were completed, i.e. on average, 33.6% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 24 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herzzentrum Leipzig GmbH" #1 sponsor was "Abbott Medical Devices" with 39 trials, followed by "University of Leipzig" with 14 trials sponsored, "Edwards Lifesciences" with 13 trials sponsored, "Leipzig Heart Institute GmbH" with 7 trials sponsored and "Symetis SA" with 7 trials sponsored. Other sponsors include 111 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herzzentrum Leipzig GmbH" #1 collaborator was "Heart Center Leipzig - University Hospital" with 13 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 6 trials as a collaborator, "Abbott" with 3 trials as a collaborator, "German Heart Center" with 3 trials as a collaborator and "Heart and Diabetes Center North Rhine-Westphalia" with 3 trials as a collaborator. Other collaborators include 213 different institutions and companies that were collaborators in the rest 196 trials.

According to Clinical.Site data, the most researched conditions in "Herzzentrum Leipzig GmbH" are "Atrial Fibrillation" (26 trials), "Aortic Valve Stenosis" (16 trials), "Heart Failure" (16 trials), "Coronary Artery Disease" (13 trials) and "Aortic Stenosis" (8 trials). Many other conditions were trialed in "Herzzentrum Leipzig GmbH" in a lesser frequency.

Most popular intervention types in "Herzzentrum Leipzig GmbH" are "Device" (138 trials), "Drug" (23 trials), "Procedure" (22 trials), "Other" (12 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "ACURATE TA™" (2 trials), "ACURATE TA™ Transapical Aortic Bioprosthesis" (2 trials), "ArcticSun" (2 trials) and "Aspirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Herzzentrum Leipzig GmbH" are 195 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Herzzentrum Leipzig GmbH". undefined are not yet recruiting, 33 are recruiting, 27 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 105 completed trials in Herzzentrum Leipzig GmbH, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Herzzentrum Leipzig GmbH, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 94 trials that are defined as “Not Applicable".